Sotera Health (SHC) Stock Price, News & Analysis

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SHC shares.
View SHC analyst ratings or view top-rated stocks.

5 Wall Street analysts have issued twelve-month price objectives for Sotera Health's shares. Their SHC share price targets range from $14.00 to $23.00. On average, they expect the company's share price to reach $17.70 in the next twelve months. This suggests a possible upside of 63.0% from the stock's current price.
View analysts price targets for SHC or view top-rated stocks among Wall Street analysts.

Sotera Health's stock was trading at $16.85 at the beginning of 2024. Since then, SHC stock has decreased by 35.5% and is now trading at $10.86.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our SHC earnings forecast.

Sotera Health will be holding an earnings conference call on Thursday, May 2nd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Sotera Health (NASDAQ:SHC) issued its quarterly earnings data on Tuesday, February, 27th. The company reported $0.26 EPS for the quarter, hitting analysts' consensus estimates of $0.26. The business earned $310.24 million during the quarter, compared to analyst estimates of $302.17 million. Sotera Health had a trailing twelve-month return on equity of 51.32% and a net margin of 4.90%. The firm's revenue was up 23.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.23 earnings per share.

ETFs with the largest weight of Sotera Health (NASDAQ:SHC) stock in their portfolio include WisdomTree U.S. SmallCap Fund (EES) and iShares Emergent Food and AgTech Multisector ETF (IVEG).Invesco S&P MidCap 400 GARP ETF (EWMC).

Sotera Health issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of 0.670-0.750 for the period, compared to the consensus earnings per share estimate of 0.870. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Sotera Health (SHC) raised $1 billion in an IPO on Friday, November 20th 2020. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets acted as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

Sotera Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.19%) and State of Michigan Retirement System (0.01%). Insiders that own company stock include Michael P Rutz, Michael P Rutz and Pincus & Co Warburg.
View institutional ownership trends.

Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.